Clinical Trials Browser

Phase 2 × Maxy G34 × Clear all

NCT00501332 2007-12-24

Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC (Docetaxel, Adriamycin, Cyclophosphamide) Chemotherapy

Phase 2 Unknown

Breast Neoplasms, Neoplasms, Neutropenia